STOCK TITAN

[144] Lemonade, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

The Form 144 filed for Lemonade, Inc. (LMND) reports a proposed sale of 5,000 common shares through Oppenheimer & Co. on the NYSE with an aggregate market value of $272,950. The shares were acquired on 06/07/2020 under an employee stock option plan and are to be paid in cash upon exercise on 08/13/2025. Outstanding shares are listed as 73,886,417, so the proposed sale equals roughly 0.0068% of outstanding stock. The filing also discloses three prior sales by the same person totaling 15,000 shares for $735,000 on 06/23/2025, 08/05/2025, and 08/11/2025. Signature and notice date fields are not shown in the provided content.

Il modulo 144 presentato per Lemonade, Inc. (LMND) segnala la proposta di vendita di 5.000 azioni ordinarie tramite Oppenheimer & Co. alla NYSE, per un valore di mercato complessivo di $272,950. Le azioni sono state acquistate il 06/07/2020 nell'ambito di un piano di opzioni azionarie per i dipendenti e saranno pagate in contanti al momento dell'esercizio il 08/13/2025. Le azioni in circolazione sono indicate in 73,886,417, quindi la vendita proposta corrisponde a circa il 0.0068% del capitale. La comunicazione riporta inoltre tre vendite precedenti effettuate dalla stessa persona per un totale di 15,000 azioni per $735,000 in data 06/23/2025, 08/05/2025 e 08/11/2025. I campi relativi a firma e data di notifica non sono mostrati nel contenuto fornito.

El Formulario 144 presentado para Lemonade, Inc. (LMND) informa una propuesta de venta de 5.000 acciones ordinarias a través de Oppenheimer & Co. en la NYSE, con un valor de mercado agregado de $272,950. Las acciones se adquirieron el 06/07/2020 bajo un plan de opciones sobre acciones para empleados y se pagarán en efectivo al ejercer el 08/13/2025. Las acciones en circulación se indican en 73,886,417, por lo que la venta propuesta equivale aproximadamente al 0.0068% del capital. La presentación también revela tres ventas previas por la misma persona que suman 15,000 acciones por $735,000 en 06/23/2025, 08/05/2025 y 08/11/2025. Los campos de firma y fecha de notificación no aparecen en el contenido proporcionado.

Lemonade, Inc. (LMND)에 대해 제출된 Form 144는 NYSE에서 Oppenheimer & Co.를 통해 5,000 보통주를 매도할 예정이며 총 시가총액은 $272,950라고 보고합니다. 해당 주식은 06/07/2020에 종업원 스톡옵션 제도 하에 취득되었고 08/13/2025행사 시 현금으로 지급될 예정입니다. 발행 주식수는 73,886,417으로 기재되어 있어, 제안된 매도는 발행주식의 약 0.0068%에 해당합니다. 제출서에는 동일인이 이전에 매도한 총 15,000주 (총액 $735,000)가 06/23/2025, 08/05/2025, 08/11/2025에 이루어졌다는 사실도 공개되어 있습니다. 서명 및 통지일 필드는 제공된 내용에 표시되어 있지 않습니다.

Le formulaire 144 déposé pour Lemonade, Inc. (LMND) signale une proposition de vente de 5 000 actions ordinaires via Oppenheimer & Co. à la NYSE, pour une valeur marchande totale de $272,950. Les actions ont été acquises le 06/07/2020 dans le cadre d'un plan d'options sur actions pour les employés et seront payées en numéraire à l'exercice le 08/13/2025. Le nombre d'actions en circulation est indiqué à 73,886,417, ainsi la vente proposée représente environ 0.0068% du capital. Le dépôt révèle également trois ventes antérieures par la même personne totalisant 15,000 actions pour $735,000 les 06/23/2025, 08/05/2025 et 08/11/2025. Les champs de signature et de date de notification ne figurent pas dans le contenu fourni.

Das eingereichte Formular 144 für Lemonade, Inc. (LMND) meldet den geplanten Verkauf von 5.000 Stammaktien über Oppenheimer & Co. an der NYSE mit einem kumulierten Marktwert von $272,950. Die Aktien wurden am 06/07/2020 im Rahmen eines Mitarbeiter-Aktienoptionsprogramms erworben und sollen am 08/13/2025 bei Ausübung in Bargeld bezahlt werden. Die ausstehenden Aktien werden mit 73,886,417 angegeben, sodass der vorgeschlagene Verkauf etwa 0.0068% des ausstehenden Bestands entspricht. Die Meldung nennt außerdem drei frühere Verkäufe derselben Person in Höhe von insgesamt 15.000 Aktien für $735,000 am 06/23/2025, 08/05/2025 und 08/11/2025. Angaben zu Unterschrift und Mitteilungsdatum sind im bereitgestellten Inhalt nicht enthalten.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine insider option exercise and sale; transaction size is immaterial relative to outstanding shares and unlikely to move the market.

The Form 144 documents a proposed sale of 5,000 common shares valued at $272,950 via Oppenheimer on the NYSE. Relative to the 73,886,417 shares outstanding, this represents approximately 0.0068%, which is negligible for market impact. The seller also disclosed three recent sales totaling 15,000 shares for $735,000, indicating prior monetizations of option-derived holdings. The securities were acquired under an employee stock option plan and are to be paid in cash upon exercise, reducing uncertainty about payment method.

TL;DR: The filing shows compliance with Rule 144 disclosure requirements, but the provided content lacks visible signature and notice date fields.

The notice includes standard Rule 144 representations and identifies the acquisition source as the issuer via an employee stock option plan. The broker and exchange are disclosed as Oppenheimer & Co. and NYSE. However, the provided extract does not display a completed signature block or a notice date, limiting confirmation of filing completion from the content alone. Multiple recent sales by the same person are disclosed and are transparent in amount and timing.

Il modulo 144 presentato per Lemonade, Inc. (LMND) segnala la proposta di vendita di 5.000 azioni ordinarie tramite Oppenheimer & Co. alla NYSE, per un valore di mercato complessivo di $272,950. Le azioni sono state acquistate il 06/07/2020 nell'ambito di un piano di opzioni azionarie per i dipendenti e saranno pagate in contanti al momento dell'esercizio il 08/13/2025. Le azioni in circolazione sono indicate in 73,886,417, quindi la vendita proposta corrisponde a circa il 0.0068% del capitale. La comunicazione riporta inoltre tre vendite precedenti effettuate dalla stessa persona per un totale di 15,000 azioni per $735,000 in data 06/23/2025, 08/05/2025 e 08/11/2025. I campi relativi a firma e data di notifica non sono mostrati nel contenuto fornito.

El Formulario 144 presentado para Lemonade, Inc. (LMND) informa una propuesta de venta de 5.000 acciones ordinarias a través de Oppenheimer & Co. en la NYSE, con un valor de mercado agregado de $272,950. Las acciones se adquirieron el 06/07/2020 bajo un plan de opciones sobre acciones para empleados y se pagarán en efectivo al ejercer el 08/13/2025. Las acciones en circulación se indican en 73,886,417, por lo que la venta propuesta equivale aproximadamente al 0.0068% del capital. La presentación también revela tres ventas previas por la misma persona que suman 15,000 acciones por $735,000 en 06/23/2025, 08/05/2025 y 08/11/2025. Los campos de firma y fecha de notificación no aparecen en el contenido proporcionado.

Lemonade, Inc. (LMND)에 대해 제출된 Form 144는 NYSE에서 Oppenheimer & Co.를 통해 5,000 보통주를 매도할 예정이며 총 시가총액은 $272,950라고 보고합니다. 해당 주식은 06/07/2020에 종업원 스톡옵션 제도 하에 취득되었고 08/13/2025행사 시 현금으로 지급될 예정입니다. 발행 주식수는 73,886,417으로 기재되어 있어, 제안된 매도는 발행주식의 약 0.0068%에 해당합니다. 제출서에는 동일인이 이전에 매도한 총 15,000주 (총액 $735,000)가 06/23/2025, 08/05/2025, 08/11/2025에 이루어졌다는 사실도 공개되어 있습니다. 서명 및 통지일 필드는 제공된 내용에 표시되어 있지 않습니다.

Le formulaire 144 déposé pour Lemonade, Inc. (LMND) signale une proposition de vente de 5 000 actions ordinaires via Oppenheimer & Co. à la NYSE, pour une valeur marchande totale de $272,950. Les actions ont été acquises le 06/07/2020 dans le cadre d'un plan d'options sur actions pour les employés et seront payées en numéraire à l'exercice le 08/13/2025. Le nombre d'actions en circulation est indiqué à 73,886,417, ainsi la vente proposée représente environ 0.0068% du capital. Le dépôt révèle également trois ventes antérieures par la même personne totalisant 15,000 actions pour $735,000 les 06/23/2025, 08/05/2025 et 08/11/2025. Les champs de signature et de date de notification ne figurent pas dans le contenu fourni.

Das eingereichte Formular 144 für Lemonade, Inc. (LMND) meldet den geplanten Verkauf von 5.000 Stammaktien über Oppenheimer & Co. an der NYSE mit einem kumulierten Marktwert von $272,950. Die Aktien wurden am 06/07/2020 im Rahmen eines Mitarbeiter-Aktienoptionsprogramms erworben und sollen am 08/13/2025 bei Ausübung in Bargeld bezahlt werden. Die ausstehenden Aktien werden mit 73,886,417 angegeben, sodass der vorgeschlagene Verkauf etwa 0.0068% des ausstehenden Bestands entspricht. Die Meldung nennt außerdem drei frühere Verkäufe derselben Person in Höhe von insgesamt 15.000 Aktien für $735,000 am 06/23/2025, 08/05/2025 und 08/11/2025. Angaben zu Unterschrift und Mitteilungsdatum sind im bereitgestellten Inhalt nicht enthalten.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the LMND Form 144 disclose?

The form discloses a proposed sale of 5,000 common shares valued at $272,950, to be sold on the NYSE through Oppenheimer & Co. on 08/13/2025.

When and how were the shares being sold acquired?

The shares were acquired on 06/07/2020 under an Employee Stock Option Plan and the payment is listed as cash upon exercise on 08/13/2025.

How many shares has this person sold in the past three months and for how much?

The filing lists three sales totaling 15,000 shares with gross proceeds of $735,000 on 06/23/2025, 08/05/2025, and 08/11/2025.

What percentage of outstanding shares does the proposed sale represent?

With 5,000 shares proposed and 73,886,417 shares outstanding, the sale is approximately 0.0068% of outstanding shares.

Does the provided filing extract include the filer signature and notice date?

No. The provided content includes the standard representation language but does not show a completed signature block or a notice date.
Lemonade Inc

NYSE:LMND

LMND Rankings

LMND Latest News

LMND Latest SEC Filings

LMND Stock Data

4.03B
59.16M
24.65%
46.21%
24.09%
Insurance - Property & Casualty
Fire, Marine & Casualty Insurance
Link
United States
NEW YORK